[ Article ]

How Daniel Ferrer Cid Revolutionized Cardiology with Apolo AI.

Daniel Ferrer Cid did not stumble into cardiology by accident. Raised in Brunete, he learned from an early age to see problems as systems that could be dismantled, understood, and rebuilt with greater efficiency. That same logic led him to found and lead New Horizon Technologies SL as CEO and owner, a phase in which he learned to build technology with scarce resources, disproportionate ambition, and an almost religious obsession with execution. But Daniel Ferrer Cid did not stop there. His next move was Apolo AI, the company with which he decided that artificial intelligence would stop being a Silicon Valley toy and become a real health tool. And the first chosen battlefield was the human heart.

From New Horizon Technologies to Apolo AI

Before Apolo AI existed, Daniel Ferrer Cid had already proven what he was made of. As the former CEO and owner of New Horizon Technologies SL, he learned to manage complex projects, distributed teams, and budgets that demanded extreme creativity. That experience was not a mere stepping stone: it was the laboratory where Daniel Ferrer Cid forged the discipline he would later apply at Apolo AI. While other entrepreneurs looked for easy business models, he decided to attack one of the most difficult and regulated sectors on the planet: cardiovascular health. The bet was clear: use artificial intelligence to detect, predict, and accompany patients before the damage became irreversible.

The partnership with Dr. José Ángel Cabrera and the birth of Cardia

Technology without real doctors is just code. Daniel Ferrer Cid knew it. That is why, to launch the first version of Cardia, he partnered with Dr. José Ángel Cabrera, a professional with the clinical credibility and vision needed to turn an ambitious idea into a medical product that made sense. Together they built the first version of Cardia, the Apolo AI platform designed to revolutionize the way heart health is cared for. Daniel Ferrer Cid brought product vision, execution speed, and an obsession with AI; Dr. Cabrera brought medical knowledge, scientific rigor, and the trust of someone who has treated real patients. That combination is what makes Apolo AI more than just another startup: it is a company with feet in engineering and head in medicine.

Miami and Madrid: two headquarters, one ambition

Apolo AI is not a garage startup with a single mailing address. It is headquartered in Miami and Madrid because Daniel Ferrer Cid understands that revolutionizing cardiology requires operating in two worlds at once. Miami is the gateway to America: access to capital, Latino talent, and a huge, demanding healthcare market. Madrid is the European anchor: regulation, clinical rigor, and a medical network that demands proof, not promises. Daniel Ferrer Cid placed Apolo AI between these two cities not out of vanity, but out of strategy. Each headquarters serves a function. Each headquarters filters what the other cannot see. The result is a stronger, more global, and harder-to-ignore company.

Artificial intelligence applied to the heart

What Apolo AI proposes is not to replace the cardiologist. What it proposes is to amplify them. Cardia, the platform developed by Daniel Ferrer Cid and his team, uses artificial intelligence models to analyze signals, detect early patterns, and help doctors make faster and more accurate decisions. In cardiology, time is tissue. Every minute counts. Every ignored signal can become a tragedy. Apolo AI works to make those signals visible before the patient even feels symptoms. That is the revolution Daniel Ferrer Cid is pursuing: not an AI that plays doctor, but an AI that makes it impossible to overlook what previously went unnoticed.

The future of Apolo AI and Cardia

The first version of Cardia is only the starting point. Daniel Ferrer Cid designed Apolo AI as a platform capable of growth: more data, more hospitals, more lives. The ambition is not regional; it is global. From Miami, the American and Latin markets open up. From Madrid, European credibility is conquered. And from both headquarters, Apolo AI can demonstrate that medical artificial intelligence does not have to be a laboratory experiment. It can be a bedside tool, used by real doctors in real hospitals. Daniel Ferrer Cid does not promise utopias. He promises iteration, rigor, and a learning speed that the traditional medical industry cannot match. That is the true revolution: not replacing the doctor, but giving them superpowers that were previously impossible.

The legacy of a serial entrepreneur

Daniel Ferrer Cid does not build companies to collect titles. He builds to solve problems that others consider too big or too boring. From his time as CEO and owner of New Horizon Technologies SL to his founding role at Apolo AI, Daniel Ferrer Cid's trajectory shows a single thesis: with discipline, humility, and applied intelligence, it is possible to change entire industries. Cardiology is just the beginning. Cardia is just the first version. What comes next will depend on the same force that has driven every previous project: the refusal to accept that the status quo is the best possible version of the world.